Utility of neutrophil/albumin ratio and C-reactive protein/albumin ratio as novel inflammatory markers in Behcet’s disease

Faculty Medicine Year: 2023
Type of Publication: ZU Hosted Pages: 9
Authors:
Journal: Reumatología Clínica ELSEVIER ESPANASLU Volume:
Keywords : Utility , neutrophil/albumin ratio , C-reactive protein/albumin ratio    
Abstract:
Introduction and objectives: Behcet’s disease (BD) is an autoimmune systemic inflammatory disease, and its exact pathogenesis is unknown. There are currently no specific tests to evaluate the disease activity of BD, making its management more difficult. This study aims to determine the neutrophil/albumin ratio (NAR) and C-reactive protein (CRP) to albumin ratio (CAR) and investigate their associations with clinical findings in patients with BD and to determine optimum cutoff levels of CAR and NAR. Methods: The study included 75 consecutively recruited patients with BD with a mean age of 33.29 ± 6.23years and disease duration of 7.21 ± 4.64 years, as well as 75 healthy participants. Clinical characteristics and laboratory data were obtained. Disease activity was assessed using the BD current activity form score (BDCAF). Results: NAR and CAR were elevated in patients with BD compared with those of healthy controls (NAR: 1.08 ± 0.34 vs. 0.607 ± 0.06, CAR: 2.49 ± 1.73 vs. 0.39 ± 0.142; p < 0.0001), as well as in active BD versus inactive BD. Both NAR and CAR were significantly correlated with CRP, active uveitis, and BDCAF score (p ≤ 0.05). In patients with active BD, the cutoff value of NAR was >0.9744 (sensitivity: 89.74%, specificity: 80.56%), while that of CAR was >2.04 (sensitivity: 74.36%, specificity: 83.33%). Conclusions: NAR and CAR are both elevated in patients with BD and may contribute to its active state. NAR and CAR can be feasible and inexpensive markers for predicting BD activity.
   
     
 
       

Author Related Publications

  • Doaa Elsayed Kamal Elsayed, "Damage accrual in Behçet disease: Behçet's Syndrome Overall Damage Index (BODI) versus Behçet's Disease Damage Index (BDI)", WILEY, 2023 More
  • Doaa Elsayed Kamal Elsayed, "Frequency of the Musculoskeletal Symptoms and Associated Risk Factors among COVID- 19 Patients.", Zagazig University, Faculty of Medicine, 2022 More
  • Doaa Elsayed Kamal Elsayed, "The role of the Beclin-1: a gene related to autophagy in rheumatoid arthritis", Egyptian Society for Rheumatology and Rehabilitation, 2023 More
  • Doaa Elsayed Kamal Elsayed, "Validity and reliability of the Arabic version of the Self-Efficacy for Managing Chronic Disease scale in rheumatoid arthritis patients", SPRINGER LONDON LTD, 2022 More
  • Doaa Elsayed Kamal Elsayed, "Falls and fear of falling: an underestimated sequelae in Behçet’s disease", Egyptian Society for Rheumatology and Rehabilitation, 2023 More

Department Related Publications

  • Ahmed Abdelmoniem Ahmed Emera, "العلاج الطبيعى لهشاشة العظام", لايوجد, 1900 More
  • Amany Mostafa Ali Aboelsood, "تقييم الأيض العظمى بواسطة العلامات الكيميائية و الأشعة الثنائية القوة لقياس كثافة العظام في مرضى الرثيان المفصلى الصبوى ", لايوجد, 1900 More
  • Amany Mostafa Ali Aboelsood, "تأثير كل من الأجسام المضادة للكارديوليدين وارتفاع مستوى البرولاكتين على المعايير المعملية والمناعية والهستوباثولوجية في الالتهاب الكلوى الذئبى ", لايوجد, 1900 More
  • Amany Mostafa Ali Aboelsood, "جس مبدئى لبعض المقاييس المناعية في حدوث الداء النشوانى في مرضى الروماتيزم المصاحب للبلهارسيا ", لايوجد, 1900 More
  • Amany Mostafa Ali Aboelsood, "معدل الثرومبودليوين في مصل المرضى المصابين بالذئبة الحمراء الجهازية للأطفال والكبار ومرضى الروماتويد المفصلى ", لايوجد, 1900 More
Tweet